The EPS projection of Nike, Inc. (NYSE:NKE) for period quarter completed 2017-02-28 is $0.62.
The EPS estimates given a week and 30-days ago were $0.62 and $0.62 correspondingly. This number 60 and 90 days before was $0.62 and $0.62 respectively. However, over last week ago, the change in EPS estimate is 0%.
For the quarter completed 1 mean estimate is $0.62 based on 14 EPS estimations. As on 2016-09-27 estimated EPS stood at $0.73 showing surprise of $0.17, or 30.36%. Following the disclosed forecasts, the standard deviation is $0.03.
The upgrade in EPS revisions were 0 a week earlier against negative revisions of 0. In last 1- month and 60-days, the upgrade in EPS revisions were 0 and 0 correspondingly, whereas for a quarter and 120-days earlier, it was 0 and 0 in that sequence.
The negative revisions of earnings per-share in the last 1-month and 60-days were 11 and 11 in that order. However, a quarter and 120-days earlier, this count was 11 and 7 correspondingly.
EPS revisions downgrade and upgrade in the last 18 days were 7 and 0, correspondingly.
Quarterly Sales Estimates
The arithmetic mean of apparent annual sales of Nike, Inc. (NYSE:NKE) is $9987.86 and the median is $10020.58. The estimate is stated by 3 analysts for the fiscal 2018.
The highest yearly projection is $10052 and lowest sales mark is $9891. This results a standard deviation of $85.341.
Almost 3 have revised sales target positively in the past week and 3 have downgraded forecasts. Depending on the stated estimates, the calculated change in target against the past week is -0.395%.
Nearly 3 revised sales projections positively over the past month and 3 have downgraded forecasts. It leads to a mean estimate deviation of -0.465%.
Just about 3 have revised sales forecast positively over the quarter and 3 have downgraded forecasts, giving a deviation of 0.216%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...